These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 33317787)
1. Immunotherapy induced enterocolitis and gastritis - What to do and when? Cheung VTF; Brain O Best Pract Res Clin Gastroenterol; 2020; 48-49():101703. PubMed ID: 33317787 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal and Hepatic Complications of Immunotherapy: Current Management and Future Perspectives. Dougan M Curr Gastroenterol Rep; 2020 Mar; 22(4):15. PubMed ID: 32185493 [TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339 [TBL] [Abstract][Full Text] [Related]
4. Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease. Abu-Sbeih H; Wang Y Inflamm Bowel Dis; 2020 Apr; 26(5):662-668. PubMed ID: 31560045 [TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis. Ibraheim H; Baillie S; Samaan MA; Abu-Sbeih H; Wang Y; Talley NJ; P Jones M; Powell N Aliment Pharmacol Ther; 2020 Nov; 52(9):1432-1452. PubMed ID: 32920854 [TBL] [Abstract][Full Text] [Related]
15. Reconceptualization of immune checkpoint inhibitor-associated gastritis. Deng YF; Cui XS; Wang L World J Gastroenterol; 2024 Sep; 30(36):4031-4035. PubMed ID: 39351252 [TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal complications of the new immune checkpoint inhibitor therapies]. Götze J; Bitzer M; Malek NP Dtsch Med Wochenschr; 2019 Dec; 144(24):1731-1736. PubMed ID: 31791080 [TBL] [Abstract][Full Text] [Related]
17. Serious immune-related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series. Bresteau C; Bonnet P; Robert C; Mussini C; Saiag P; Buecher B; Lebbe C; Allez M; Benamouzig R; Hagège H; Bécheur H; Meyer A; Carbonnel F J Gastroenterol Hepatol; 2023 Dec; 38(12):2104-2110. PubMed ID: 37710354 [TBL] [Abstract][Full Text] [Related]
18. Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors. de Malet A; Antoni G; Collins M; Soularue E; Marthey L; Vaysse T; Coutzac C; Chaput N; Mateus C; Robert C; Carbonnel F Eur J Cancer; 2019 Jan; 106():106-114. PubMed ID: 30476730 [TBL] [Abstract][Full Text] [Related]
19. Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors. Velev M; Baroudjian B; Pruvost R; De Martin E; Laparra A; Babai S; Teysseire S; Danlos FX; Albiges L; Bernigaud C; Benderra MA; Pradère P; Zaidan M; Decroisette C; Fallah F; Matergia G; Lavaud P; Jantzem H; Atzenhoffer M; Buyse V; Ammari S; Robert C; Champiat S; Messayke S; Marabelle A; Guettier C; Lebbe C; Lambotte O; Michot JM Eur J Cancer; 2023 Jan; 179():28-47. PubMed ID: 36473326 [TBL] [Abstract][Full Text] [Related]
20. Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis. Ma BT; Sang LX; Chang B World J Gastroenterol; 2024 Jun; 30(24):3123-3125. PubMed ID: 38983955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]